Multimodal microscope system for pharmaceutical particle analysis

The contract involves the acquisition of the mIRage-LS sub-micron IR multimodal microscope system, an advanced analytical platform designed primarily for pharmaceutical particle analysis. This state-of-the-art system combines Optical Photothermal Infrared spectroscopy with simultaneous Raman and fluorescence microscopy, enabling highly detailed chemical and morphological characterization of particles at spatial resolutions below 500 nanometers. This integrated approach allows for a comprehensive analysis within a single workflow, significantly enhancing the precision and efficiency of particle characterization in pharmaceutical applications. The contract is forecasted by the Food and Drug Administration under the NAICS code 334516, reflecting its focus on optical instrument manufacturing. Specific details such as solicitation number, place of performance, and contracting officer information are either pending or to be determined. The FDA's acquisition liaison is the point of contact for this procurement, indicating the agency's commitment to upgrading its analytical capabilities in support of regulatory science and pharmaceutical quality control.